Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) EBIT: 2013-2022

Historic EBIT for Cellectis (CLLS) over the last 10 years, with Dec 2022 value amounting to -$89.7 million.

  • Cellectis' EBIT rose 24.43% to -$20.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$73.4 million, marking a year-over-year increase of 32.34%. This contributed to the annual value of -$89.7 million for FY2022, which is 13.35% up from last year.
  • Latest data reveals that Cellectis reported EBIT of -$89.7 million as of FY2022, which was up 13.35% from -$103.5 million recorded in FY2021.
  • Over the past 5 years, Cellectis' EBIT peaked at -$42.3 million during FY2020, and registered a low of -$123.6 million during FY2019.
  • For the 3-year period, Cellectis' EBIT averaged around -$78.5 million, with its median value being -$89.7 million (2022).
  • As far as peak fluctuations go, Cellectis' EBIT spiked by 65.75% in 2020, and later plummeted by 144.57% in 2021.
  • Yearly analysis of 5 years shows Cellectis' EBIT stood at -$105.1 million in 2018, then declined by 17.57% to -$123.6 million in 2019, then surged by 65.75% to -$42.3 million in 2020, then tumbled by 144.57% to -$103.5 million in 2021, then increased by 13.35% to -$89.7 million in 2022.